$693.46
0.47% yesterday
NYSE, May 09, 10:00 pm CET
ISIN
US58155Q1031
Symbol
MCK

McKesson Stock price

$693.46
+21.70 3.23% 1M
+77.87 12.65% 6M
+123.55 21.68% YTD
+138.34 24.92% 1Y
+366.99 112.41% 3Y
+553.20 394.41% 5Y
+464.92 203.43% 10Y
NYSE, Closing price Fri, May 09 2025
+3.21 0.47%
ISIN
US58155Q1031
Symbol
MCK
Sector

Key metrics

Market capitalization $86.91b
Enterprise Value $88.99b
P/E (TTM) P/E ratio 26.86
EV/FCF (TTM) EV/FCF 16.04
EV/Sales (TTM) EV/Sales 0.25
P/S ratio (TTM) P/S ratio 0.24
P/B ratio (TTM) P/B ratio negative
Dividend yield 0.40%
Last dividend (FY25) $2.75
Revenue growth (TTM) Revenue growth 16.22%
Revenue (TTM) Revenue $359.05b
EBIT (operating result TTM) EBIT $4.76b
Free Cash Flow (TTM) Free Cash Flow $5.55b
Cash position $5.69b
EPS (TTM) EPS $25.82
P/E forward 19.79
P/S forward 0.21
EV/Sales forward 0.22
Short interest 1.52%
Show more

Is McKesson a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,791 stocks worldwide.

McKesson Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a McKesson forecast:

14x Buy
74%
4x Hold
21%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a McKesson forecast:

Buy
74%
Hold
21%
Sell
5%

Financial data from McKesson

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
359,051 359,051
16% 16%
100%
- Direct Costs 346,090 346,090
17% 17%
96%
13,446 13,446
10% 10%
4%
- Selling and Administrative Expenses 8,204 8,204
7% 7%
2%
- Research and Development Expense - -
-
-
5,393 5,393
18% 18%
2%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 4,757 4,757
21% 21%
1%
Net Profit 3,295 3,295
10% 10%
1%

In millions USD.

Don't miss a Thing! We will send you all news about McKesson directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

McKesson Stock News

Positive
The Motley Fool
about 19 hours ago
Storied healthcare supplies company McKesson (MCK 0.34%) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. They liked, if not loved, what they saw, sending the shares to a 0.5% gain on that day.
Positive
Seeking Alpha
about 24 hours ago
I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8% adj. EPS growth, largely driven by strong demand for GLP-1 products, which now represent 12% of total revenue. The company's global supply chain flexibility and non-discretionary drug pricing rend...
Neutral
Seeking Alpha
one day ago
McKesson Corporation (NYSE:MCK ) Q4 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Jeni Dominguez - VP of Investor Relations Conference Call Participants Kevin Caliendo - UBS Lisa Gill - JP Morgan Allen Lutz - Bank of America Eric Percher - Nephron Research Stephen Baxter - Wells Fargo Dani...
More McKesson News

Company Profile

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Head office United States
CEO Brian Tyler
Founded 1833
Website www.mckesson.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today